| Q48300002 | APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38. |
| Q33572654 | Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif |
| Q28828789 | Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease? |
| Q34467478 | Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ. |
| Q39584972 | Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds |
| Q35029086 | Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease |
| Q33885289 | Beta-amyloid precursor protein mutants respond to gamma-secretase modulators |
| Q36559869 | Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET |
| Q30363483 | Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations. |
| Q36081889 | Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease |
| Q36668200 | Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models |
| Q38101383 | Development and mechanism of γ-secretase modulators for Alzheimer's disease |
| Q35498267 | Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations |
| Q52331406 | Dysfunctional γ-Secretase in Familial Alzheimer's Disease. |
| Q36674203 | Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD |
| Q41907099 | Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid |
| Q38693441 | Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified? |
| Q48299006 | Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37). |
| Q40506355 | Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome |
| Q90661748 | Helix-Switch Enables C99 Dimer Transition between the Multiple Conformations |
| Q35913521 | Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans |
| Q48031219 | Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study |
| Q55516241 | Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study. |
| Q51770733 | Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer’s disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure |
| Q36294856 | Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production |
| Q33496258 | Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels |
| Q47222878 | Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease |
| Q35562828 | Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein |
| Q33726342 | The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) Profile without affecting Notch processing |
| Q36000134 | The mechanism of γ-Secretase dysfunction in familial Alzheimer disease |
| Q37591341 | Transmembrane fragment structures of amyloid precursor protein depend on membrane surface curvature. |
| Q39285976 | Unlocking truths of γ-secretase in Alzheimer's disease: what is the translational potential? |
| Q39451354 | Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment |
| Q35871906 | γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP). |
| Q41831750 | γ-Secretase associated with lipid rafts: multiple interactive pathways in the stepwise processing of β-carboxyl-terminal fragment |
| Q26830462 | γ-Secretase inhibitors and modulators |